Author

Rong Lin

Institutions: Cara Therapeutics (United States), Biostatistical Consulting (United States)

Observed institutions: Cara Therapeutics (United States), Biostatistical Consulting (United States)

OpenAlex ID: A5034744787

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies

2022 · Joel Topf, Thomas Wooldridge, et al. · Kidney Medicine · 106

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program

2022 · Steven Fishbane, Warren Wen, et al. · Kidney Medicine · 51

Works count: 2

Citation count: 157

H-index: 2

I10-index: 2